CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0337

Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg)

Filed under Injectable Oils. The bureau holds 163 laboratory returns for this compound from 60 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

60 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760 A 5 10.0 9.9 10.0 25 May 2026 25 May 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 4 10.0 9.9 10.0 21 Nov 2025 14 Jun 2026
Kerui PeptidesCASE #VI-2026-0626 A 4 10.0 10.0 10.0 15 Feb 2026 14 Apr 2026
WuXi TIDESCASE #VI-2026-0335 A 4 10.0 9.9 10.0 13 Dec 2025 26 May 2026
Hubei JianxiangCASE #VI-2026-0048 A 3 10.0 9.9 10.0 7 Mar 2026 2 Jun 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 3 10.0 9.9 10.0 10 Jan 2026 7 May 2026
GenScript PeptidesCASE #VI-2026-0860 A 3 10.0 10.0 10.0 20 Feb 2026 3 Aug 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 10.0 10.0 10.0 26 Dec 2025 20 Apr 2026
AsymchemCASE #VI-2026-0091 A 3 10.0 9.9 10.0 27 May 2026 14 Jul 2026
AmbioPharmCASE #VI-2026-0177 A 3 10.0 9.9 10.0 21 Jan 2026 24 May 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 2 10.0 10.0 10.0 26 Jun 2026 28 Jun 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 10.0 10.0 10.0 18 May 2026 7 Jun 2026
PeptiSlimCASE #VI-2026-0557 X 2 10.0 10.0 10.0 13 Feb 2025 21 May 2026
NUPEPS PeptidesCASE #VI-2026-0896 X 1 10.0 10.0 10.0 17 Dec 2024 17 Dec 2024
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 4 9.9 9.9 10.0 14 Nov 2025 16 Apr 2026
SinoPepCASE #VI-2026-0387 A 4 9.9 9.9 10.0 22 May 2026 11 Aug 2026
Sangon BioCASE #VI-2026-0671 A 3 9.9 9.9 10.0 1 Apr 2026 26 May 2026
BachemCASE #VI-2026-0314 A 3 9.9 9.9 9.9 5 Feb 2026 12 Jul 2026
Sigma-AldrichCASE #VI-2026-0829 A 3 9.9 9.9 10.0 9 Mar 2026 12 Jun 2026
QYAOBIOCASE #VI-2026-0861 A 2 9.9 9.9 10.0 16 Mar 2026 24 Jun 2026
JEEP PeptidesCASE #VI-2026-0457 A 2 9.9 9.9 10.0 21 Mar 2026 28 May 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 2 9.9 9.9 10.0 2 Jul 2026 11 Jul 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 2 9.9 9.9 9.9 7 May 2026 12 Jul 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 2 9.9 9.9 10.0 7 Aug 2026 13 Aug 2026
PolyPeptide GroupCASE #VI-2026-0143 A 2 9.9 9.9 9.9 6 May 2026 14 Aug 2026
Yiwu Aozuo Trading CoCASE #VI-2026-0798 X 2 9.7 9.5 9.9 2 Apr 2025 21 May 2026
Xingtai Pukelai Technology CoCASE #VI-2026-0850 X 1 9.4 9.4 9.4 17 Dec 2024 17 Dec 2024
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 5 9.3 8.5 10.0 25 May 2026 25 May 2026
LN PeptidesCASE #VI-2026-0781 X 1 9.2 9.2 9.2 3 Jun 2025 3 Jun 2025
Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 X 1 9.1 9.1 9.1 3 Jun 2025 3 Jun 2025
HkRoidsCASE #VI-2026-0784 X 1 9.1 9.1 9.1 28 Mar 2025 28 Mar 2025
Peptide HavenCASE #VI-2026-0898 X 1 8.3 8.3 8.3 8 Jul 2025 8 Jul 2025
Glbiochem (Shanghai)CASE #VI-2026-0704 A 7 8.2 7.5 9.2 23 May 2026 23 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 6 8.2 6.0 9.8 25 May 2026 25 May 2026
Lux Synth AminosCASE #VI-2026-0700 X 1 8.0 8.0 8.0 3 Jun 2025 3 Jun 2025
NextGen HealthCASE #VI-2026-0604 X 1 7.9 7.9 7.9 2 Apr 2025 2 Apr 2025
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 5 7.8 6.9 9.6 24 May 2026 24 May 2026
Yabang PeptideCASE #VI-2026-0148 X 1 7.8 7.8 7.8 13 Feb 2025 13 Feb 2025
AKS ChemCASE #VI-2026-0313 X 1 7.8 7.8 7.8 2 Jul 2025 2 Jul 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 3 7.7 6.8 8.6 24 May 2026 24 May 2026
LiliPeptideCASE #VI-2026-0695 X 3 7.7 5.6 10.0 3 Jun 2025 24 May 2026
Aavant ResearchCASE #VI-2026-0831 X 1 7.7 7.7 7.7 14 Jan 2025 14 Jan 2025
Changan District Sheng Peptide TradingCASE #VI-2026-0341 X 1 7.7 7.7 7.7 20 Jun 2025 20 Jun 2025
Mai PeptideCASE #VI-2026-0769 X 5 7.6 4.6 10.0 17 Dec 2024 21 May 2026
Liberty PeptidesCASE #VI-2026-0416 X 1 7.6 7.6 7.6 2 Jul 2025 2 Jul 2025
Qing Li PeptideCASE #VI-2026-0469 X 3 7.3 6.1 8.3 13 Jun 2025 21 May 2026
TCICASE #VI-2026-0650 X 1 7.1 7.1 7.1 27 Feb 2025 27 Feb 2025
Royal PeptidesCASE #VI-2026-0264 X 2 7.0 6.8 7.2 2 Apr 2025 24 May 2026
ZLZ PeptideCASE #VI-2026-0524 X 12 6.8 3.8 9.1 3 Jun 2025 21 May 2026
Reta-PeptideCASE #VI-2026-0756 X 7 6.5 4.3 9.6 2 Jul 2025 24 May 2026
Mix PeptidesCASE #VI-2026-0699 X 2 6.5 4.9 8.0 13 Feb 2025 26 Jan 2026
Verified PeptidesCASE #VI-2026-0407 X 3 6.3 4.5 8.8 9 Jun 2025 24 May 2026
Biolongevity LabsCASE #VI-2026-0442 X 3 6.0 5.0 7.5 8 Jul 2025 21 May 2026
Allen Biotechnology Co ABCCASE #VI-2026-0709 X 4 5.4 2.8 7.4 2 Jul 2025 20 May 2026
WllyBIOCASE #VI-2026-0470 X 1 5.3 5.3 5.3 16 Mar 2025 16 Mar 2025
LipeptidesCASE #VI-2026-0863 X 1 5.1 5.1 5.1 21 May 2025 21 May 2025
Top PeptideCASE #VI-2026-0721 X 1 5.1 5.1 5.1 16 Mar 2025 16 Mar 2025
Peptides 4 ResearchCASE #VI-2026-0511 X 2 5.0 3.6 6.3 8 Jul 2025 19 Jan 2026
Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 X 1 3.6 3.6 3.6 2 Jul 2025 2 Jul 2025
LOOKBiotechCASE #VI-2026-0807 X 1 0.9 0.9 0.9 27 Feb 2025 27 Feb 2025

Open any subject to view the batch-level evidence for Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) alone.